Refresh

Elder Pharmaceuticals Ltd. - Research Center

532322 ELDERPHARM Group (Z) BSE data
Back to Company

Results

Statement

More

Annual results in brief
(Rs crore)
Jun ' 14 Jun ' 13 Mar ' 13 Mar ' 12 Mar ' 11

Sales

483.47 1,233.10 1,043.85 982.64 827.16

Operating profit

-88.10 269.07 211.18 210.07 176.16

Interest

260.06 137.97 94.32 77.89 62.00

Gross profit

-333.03 157.31 143.24 140.67 120.03

EPS (Rs)

8.37 45.64 42.34 41.70 34.71
Annual  results in details
Jun ' 14 Jun ' 13 Mar ' 13 Mar ' 12 Mar ' 11

Other income

15.13 26.22 26.38 8.49 5.86

Stock adjustment

127.68 57.16 24.43 -36.99 -34.07

Raw material

48.84 122.47 109.59 115.53 119.32

Power and fuel

- - - - -

Employee expenses

116.39 157.49 126.08 118.99 105.51

Excise

- - - - -

Admin and selling expenses

- - - - -

Research and development expenses

- - - - -

Expenses capitalised

- - - - -

Other expenses

278.66 626.91 572.56 575.04 460.23

Provisions made

- - - - -

Depreciation

29.16 36.52 29.19 27.15 27.25

Taxation

0.67 21.97 22.00 21.59 16.50

Net profit / loss

17.18 93.74 86.96 85.64 71.29

Extra ordinary item

380.04 -5.09 -5.09 -6.29 -4.99

Prior year adjustments

- - - - -

Equity capital

20.54 20.54 20.54 20.54 20.54

Equity dividend rate

- - - - -

Agg.of non-prom. shares (Lacs)

153.49 134.72 123.24 124.05 126.38

Agg.of non promotoholding (%)

74.74 65.60 60.01 60.40 61.54

OPM (%)

-18.22 21.82 20.23 21.38 21.30

GPM (%)

-66.79 12.49 13.38 14.19 14.41

NPM (%)

3.45 7.44 8.13 8.64 8.56
Sectoral Indices Market Indicators Listed Companies Gainers Losers Mutual Funds Portfolio Watchlist
© 2024 Rediff.com